1372514 - Eyegate Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - EYEG (1372514)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
42 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S2-4-4-14+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2018-12-10
EYEGArmistice Capital, LLCDir, 10%P - Purchase$0.40+100,35334,525,7060%+$40,316
DM
2018-11-14
EYEGArmistice Capital, LLCDir, 10%P - Purchase$0.45+360,00034,325,000+1%+$161,395
2018-07-10
EYEGGaranzini MichaelChief Commercial OfficerA - Grant$0.00+25,000196,250+15%+$0
2018-07-10
EYEGManzo Michael P.VP of EngineeringA - Grant$0.00+175,000194,546+895%+$0
2018-07-10
EYEGFrom StephenPres, CEOA - Grant$0.00+750,0001,159,820+183%+$0
2018-07-10
EYEGMalfroy-Camine BernardDirA - Grant$0.00+50,00061,525+434%+$0
2018-07-10
EYEGGoldberg MortonDirA - Grant$0.00+50,00059,441+530%+$0
2018-07-10
EYEGChaney Paul GDirA - Grant$0.00+50,00091,229+121%+$0
2018-07-10
EYEGMann BrendaVP of Research, DevelopmentA - Grant$0.00+175,000193,473+947%+$0
2018-07-10
EYEGTyle PraveenDirA - Grant$0.00+50,00061,893+420%+$0
2018-07-10
EYEGRomano SarahCFOA - Grant$0.00+175,000281,863+164%+$0
2018-07-10
EYEGWirostko BarbaraChief Medical OfficerA - Grant$0.00+175,000484,912+56%+$0
AM
2018-06-07
EYEGWirostko BarbaraChief Medical OfficerA - Grant$0.53+18,815309,912+6%+$9,924
M
2018-06-07
EYEGWirostko BarbaraChief Medical OfficerA - Grant$0.54+9,215300,312+3%+$4,932
M
2018-05-25
EYEGArmistice Capital, LLCDir, 10%P - Purchase$0.57+58,27533,605,0000%+$33,433
2018-05-18
EYEGArmistice Capital, LLCDir, 10%P - Purchase$0.56+1,72533,488,4500%+$959
2018-05-14
EYEGArmistice Capital, LLCDir, 10%P - Purchase$0.53+15,75833,485,0000%+$8,417
M
2018-05-09
EYEGArmistice Capital, LLC10%P - Purchase$0.51+177,01233,453,484+1%+$90,992
M
2018-05-04
EYEGArmistice Capital, LLC10%P - Purchase$0.46+137,23033,099,4600%+$63,472
M
2018-04-25
EYEGArmistice Capital, LLC10%P - Purchase$0.54+165,52232,825,000+1%+$89,266
M
2018-04-18
EYEGArmistice Capital, LLC10%P - Purchase$0.49+2,534,47832,493,956+8%+$1,231,159
D
2018-04-17
EYEGGaranzini MichaelChief Commercial OfficerP - Purchase$0.00+156,250171,250>999%+$0
D
2018-04-17
EYEGFrom StephenPres, CEOP - Purchase$0.00+125,000409,820+44%+$0
D
2018-04-17
EYEGRomano SarahCFOP - Purchase$0.00+62,500106,863+141%+$0
DM
2018-04-13
EYEGArmistice Capital, LLC10%P - Purchase$0.36+10,479,97027,425,000+62%+$3,740,050
2017-11-17
EYEGGaranzini MichaelChief Commercial OfficerA - Grant$1.07+15,00015,000New+$16,050
M
2017-09-14
EYEGWirostko BarbaraChief Medical OfficerA - Grant$1.22+19,200278,742+7%+$23,334
2017-08-15
EYEGRomano SarahInterim CFOP - Purchase$1.00+10,00032,500+44%+$10,000
2017-08-10
EYEGFrom StephenPres, CEOP - Purchase$1.03+12,500272,465+5%+$12,875
D
2017-06-14
EYEGRomano SarahInterim CFOP - Purchase$0.00+20,00022,500+800%+$0
D
2017-06-14
EYEGFrom StephenPres, CEOP - Purchase$0.00+60,000259,965+30%+$0
D
2017-06-02
EYEGChaney Paul GDirM - OptEx$0.65+17,57041,229+74%+$11,421
D
2017-05-15
EYEGManzo Michael P.VP of EngineeringM - OptEx$0.65+7,28519,546+59%+$4,735
2017-03-13
EYEGVentech Capital II10%S - Sale$2.80-4,4191,431,8140%-$12,385-4-1-13
2017-03-07
EYEGWirostko BarbaraChief Medical OfficerA - Grant$2.83+8,700259,542+3%+$24,621-7-3-12
2017-03-06
EYEGGoldberg MortonDirS - Sale$3.00-8,9199,441-49%-$26,757-4-8-15
2017-02-28
EYEGWirostko BarbaraChief Medical OfficerA - Grant$2.59+95,900250,842+62%+$248,798-4+1-11
D
2017-02-27
EYEGGoldberg MortonDirM - OptEx$1.70+1,08318,360+6%+$1,841-4+1-11
2017-02-06
EYEGRomano SarahInterim CFOA - Grant$0.00+2,5002,500New+$0+4+4+61
2017-02-06
EYEGMann BrendaVP of Research, DevelopmentA - Grant$0.00+2,50011,751+27%+$0+1+5+66
2017-02-06
EYEGWirostko BarbaraChief Medical OfficerA - Grant$0.00+15,000154,942+11%+$0+1+5+66
2017-02-06
EYEGFrom StephenPres, CEOA - Grant$0.00+60,000199,965+43%+$0+1+5+66
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top